STOCK TITAN
  1. Home
  2. Sec-filings
  3. LILA
  4. [Form 4] Liberty Latin America Ltd. Insider Trading Activity

Liberty Latin America CFO receives special share dividend

NOYES CHRISTOPHER J reported acquisition or exercise transactions in this Form 4 filing.

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

NOYES CHRISTOPHER J reported acquisition or exercise transactions in this Form 4 filing.

Liberty Latin America Ltd. declared a special dividend of 0.10 newly issued 9.0% Series A Preferred Share, with a $25 liquidation price, for each outstanding common share. CFO Christopher J. Noyes received 88,634 Series A Preference Shares directly and 4,075 indirectly via an IRA, plus new Preferred-share RSUs linked to existing common‑stock RSUs. Share appreciation rights on Class A and C common shares were adjusted under anti‑dilution provisions, with revised share amounts, base prices and vesting terms summarized.

Positive

  • None.

Negative

  • None.
Insider NOYES CHRISTOPHER J
Role SVP, CHIEF FINANCIAL OFFICER
Type Security Shares Price Value
Other Restricted Share Units P F2, F3, F4 7,873 $0.00 $0.00
Other Restricted Share Units P F2, F3, F5 14,953 $0.00 $0.00
Other Restricted Share Units P F2, F3, F6 19,354 $0.00 $0.00
Other Series A Preference Shares F1 88,634 $0.00 $0.00
Other Series A Preference Shares F1 4,075 $0.00 $0.00
holding Share Appreciation Rights A F7, F8 -- -- --
holding Share Appreciation Rights C F7, F9 -- -- --
holding Share Appreciation Rights A F7, F10 -- -- --
holding Share Appreciation Rights C F7, F11 -- -- --
holding Share Appreciation Rights A F7, F12 -- -- --
holding Share Appreciation Rights C F7, F13 -- -- --
holding Share Appreciation Rights A F7, F14 -- -- --
holding Share Appreciation Rights C F7, F15 -- -- --
holding Share Appreciation Rights A F7, F16 -- -- --
holding Share Appreciation Rights C F7, F17 -- -- --
holding Share Appreciation Rights A F7, F18 -- -- --
holding Share Appreciation Rights C F7, F19 -- -- --
holding Share Appreciation Rights A F7, F20 -- -- --
holding Share Appreciation Rights C F7, F21 -- -- --
holding Share Appreciation Rights A F7, F22 -- -- --
holding Share Appreciation Rights C F7, F23 -- -- --
holding Share Appreciation Rights A F24, F25 -- -- --
holding Share Appreciation Rights C F24, F26 -- -- --
holding Share Appreciation Rights A F27, F28 -- -- --
holding Share Appreciation Rights C F27, F29 -- -- --
holding Share Appreciation Rights A F30, F31 -- -- --
holding Share Appreciation Rights C F30, F32 -- -- --
Holdings After Transaction: Restricted Share Units P — 42,180 contracts (Direct); Series A Preference Shares — 88,634 shares (Direct); Series A Preference Shares — 4,075 shares (Indirect, By IRA); Share Appreciation Rights A — 1,344,124 contracts (Direct); Share Appreciation Rights C — 2,763,448 contracts (Direct)
Footnotes (32)
  1. F1. On May 21, 2026, the Issuer announced that an authorized committee of the Issuer's board of directors declared a special dividend on each of its outstanding common shares payable on June 16, 2026 to all holders of record as of 5:00 p.m., New York City time, on June 1, 2026 consisting of a special dividend of 0.10 shares of newly issued 9.0% Fixed Rate Cumulative Perpetual Redeemable Series A Preferred Shares (the "Preferred Shares"), having an initial liquidation price of $25 per Preferred Share (the "Dividend"). As a result of the Dividend, the reporting person directly received 88,634 Preferred Shares.
  2. F2. Each Restricted Share Unit P ("RSU") represents a right to receive one share of the Issuer's Series A Preference Shares at settlement.
  3. F3. In connection with the Dividend, all RSUs with respect to the Issuer's common stock ("Original RSUs") were adjusted pursuant to the anti-dilution provisions of the incentive plans under which the RSU awards held by the reporting person were granted. Each holder of an Original RSU was entitled to receive an RSU with respect to a number of Preferred Shares equal to 0.10 multiplied by the number of shares of common stock underlying the Original RSU, subject to the same terms and conditions as the Original RSU. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  4. F4. The Restricted Share Units vest in full on March 15, 2027.
  5. F5. The RSUs vest in two equal annual installments on March 15 of 2027 and 2028.
  6. F6. The RSUs vest in three equal annual installments on March 15 of 2027, 2028 and 2029.
  7. F7. The derivative security is fully vested.
  8. F8. This SAR was previously reported as a SAR relating to 11,854 shares of the Issuer's common stock at a base price of $21.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  9. F9. This SAR was previously reported as a SAR relating to 23,708 shares of the Issuer's common stock at a base price of $21.39 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  10. F10. This share appreciation right award ("SAR") was previously reported as a SAR relating to 28,935 shares of the Issuer's common stock at a base price of $18.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  11. F11. This SAR was previously reported as a SAR relating to 57,870 shares of the Issuer's common stock at a base price of $18.24 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  12. F12. This SAR was previously reported as a SAR relating to 28,345 shares of the Issuer's common stock at a base price of $19.91 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  13. F13. This SAR was previously reported as a SAR relating to 56,690 shares of the Issuer's common stock at a base price of $20.03 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  14. F14. This SAR was previously reported as a SAR relating to 50,939 shares of the Issuer's common stock at a base price of $10.42 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  15. F15. This SAR was previously reported as a SAR relating to 101,878 shares of the Issuer's common stock at a base price of $10.48 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  16. F16. This SAR was previously reported as a SAR relating to 100,000 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  17. F17. This SAR was previously reported as a SAR relating to 200,000 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  18. F18. This SAR was previously reported as a SAR relating to 75,331 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  19. F19. This SAR was previously reported as a SAR relating to 150,662 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  20. F20. This SAR was previously reported as a SAR relating to 115,660 shares of the Issuer's common stock at a base price of $9.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  21. F21. This SAR was previously reported as a SAR relating to 231,320 shares of the Issuer's common stock at a base price of $9.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  22. F22. This SAR was previously reported as a SAR relating to 120,163 shares of the Issuer's common stock at a base price of $7.81 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  23. F23. This SAR was previously reported as a SAR relating to 240,326 shares of the Issuer's common stock at a base price of $7.78 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  24. F24. The SARs vest fully on March 15 2027.
  25. F25. This SAR was previously reported as a SAR relating to 149,031 shares of the Issuer's common stock at a base price of $6.16 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  26. F26. This SAR was previously reported as a SAR relating to 298,062 shares of the Issuer's common stock at a base price of $6.22 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  27. F27. The Share Appreciation Rights vest in two equal annual installments commencing on March 15 2027 and 2028.
  28. F28. This SAR was previously reported as a SAR relating to 137,741 shares of the Issuer's common stock at a base price of $6.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  29. F29. This SAR was previously reported as a SAR relating to 275,482 shares of the Issuer's common stock at a base price of $6.66 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  30. F30. The Share Appreciation Rights vest in three equal annual installments on March 15 of 2027, 2028 and 2029.
  31. F31. This SAR was previously reported as a SAR relating to 121,951 shares of the Issuer's common stock at a base price of $7.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  32. F32. This SAR was previously reported as a SAR relating to 243,902 shares of the Issuer's common stock at a base price of $7.77 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
Special dividend rate 0.10 shares Preferred Shares issued per outstanding common share as a special dividend
Preferred coupon rate 9.0% Fixed rate on Series A Preferred Shares distributed as the dividend
Preferred liquidation price $25 Initial liquidation price per Series A Preferred Share
Direct Preferred Shares to CFO 88,634 shares Series A Preference Shares directly received by Christopher J. Noyes from the dividend
Indirect Preferred Shares via IRA 4,075 shares Series A Preference Shares held indirectly by IRA after the dividend
New Preferred-share RSUs block 1 19,354 units Restricted Share Units P for Series A Preference Shares, vesting fully on March 15, 2027
New Preferred-share RSUs block 2 14,953 units RSUs vesting in two equal annual installments on March 15, 2027 and 2028
Class C SAR position example 340,040 shares at $6.5600 Share Appreciation Rights on Class C Common Shares expiring March 11, 2032
Restricted Share Unit financial
"Each Restricted Share Unit P ("RSU") represents a right to receive one share"
A restricted share unit (RSU) is a promise by a company to give an employee a set number of company shares at a future date, typically after meeting time or performance conditions. For investors, RSUs matter because when they convert into actual shares they increase the number of shares outstanding (like unlocking more tickets in a game), which can dilute existing holders, and they align employee incentives with company performance, influencing behavior and long-term value.
Share Appreciation Right financial
"This SAR was previously reported as a SAR relating to 56,690 shares"
anti-dilution provisions financial
"were adjusted pursuant to the anti-dilution provisions of the incentive plans"
Anti-dilution provisions are contract terms that protect an investor’s percentage ownership when a company issues new shares at a lower price than the investor originally paid. They work like an automatic recalculation of split pieces when a pie gets cut into more slices, preserving the investor’s relative stake and reducing unexpected losses of ownership and voting power, which matters because it affects potential control, future returns, and valuation of an investment.
9.0% Fixed Rate Cumulative Perpetual Redeemable Series A Preferred Shares financial
"a special dividend of 0.10 shares of newly issued 9.0% Fixed Rate Cumulative"
liquidation price financial
"having an initial liquidation price of $25 per Preferred Share"

FAQ

What special dividend did Liberty Latin America (LILA) declare in 2026?
Liberty Latin America declared a special dividend of 0.10 newly issued 9.0% Series A Preferred Share for each outstanding common share. It is payable on June 16, 2026 to holders of record at 5:00 p.m. New York time on June 1, 2026, with a $25 liquidation price per Preferred Share.

How many Series A Preference Shares did LILA CFO Christopher J. Noyes receive?
CFO Christopher J. Noyes received 88,634 Series A Preference Shares directly as a result of the special dividend and 4,075 Series A Preference Shares indirectly through an IRA. These holdings are reported as non-derivative positions following the June 16, 2026 dividend payment.

How were Christopher Noyes' RSUs adjusted after LILA’s special dividend?
All RSUs tied to LILA common stock were adjusted so each Original RSU generated an RSU for 0.10 Series A Preferred Share. For Christopher Noyes, this created new Preferred-share RSUs of 19,354, 14,953, and 7,873 units, each carrying vesting terms that mirror the underlying Original RSUs.

What are the vesting schedules of the new RSUs reported for LILA’s CFO?
One block of Restricted Share Units vests in full on March 15, 2027. A second block vests in two equal annual installments on March 15, 2027 and March 15, 2028, while a third vests in three equal annual installments on March 15 of 2027, 2028, and 2029.

What changes occurred to LILA share appreciation rights in this Form 4?
Share appreciation rights (SARs) on Class A and Class C common shares held by Christopher Noyes were adjusted under anti-dilution provisions due to the special dividend. The number of shares subject to each SAR and its base price were revised, with examples now covering up to 438,151 underlying Class C shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
NOYES CHRISTOPHER J
(Last)(First)(Middle)
1550 WEWATTA STREET
SUITE 800
(Street)
DENVER COLORADO 80202
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Liberty Latin America Ltd. [ LILA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP, CHIEF FINANCIAL OFFICER
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Series A Preference Shares06/16/2026JV88,634A$088,634(1)D
Series A Preference Shares06/16/2026JV4,075A$04,075(1)IBy IRA
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Share Units P(2)06/17/2026JV7,873(3) (4) (4)Series A Preference Shares7,873(3)$07,873D
Restricted Share Units P(2)06/17/2026JV14,953(3) (5) (5)Series A Preference Shares14,953(3)$014,953D
Restricted Share Units P(2)06/17/2026JV19,354(3) (6) (6)Series A Preference Shares19,354(3)$019,354D
Share Appreciation Rights A$15.1 (7)01/02/2028Class A Common Shares16,951(8)16,951D
Share Appreciation Rights C$14.56 (7)01/02/2028Class C Common Shares34,850(9)34,850D
Share Appreciation Rights A$13.03 (7)05/01/2028Class A Common Shares41,377(10)41,377D
Share Appreciation Rights C$12.41 (7)05/01/2028Class C Common Shares85,068(11)85,068D
Share Appreciation Rights A$13.93 (7)05/01/2029Class A Common Shares40,533(12)40,533D
Share Appreciation Rights C$13.63 (7)05/01/2029Class C Common Shares83,334(13)83,334D
Share Appreciation Rights A$7.29 (7)03/16/2030Class A Common Shares72,842(14)72,842D
Share Appreciation Rights C$7.13 (7)03/16/2030Class C Common Shares149,760(15)149,760D
Share Appreciation Rights A$9.8 (7)03/16/2031Class A Common Shares143,000(16)143,000D
Share Appreciation Rights C$9.6 (7)03/16/2031Class C Common Shares294,000(17)294,000D
Share Appreciation Rights A$9.8 (7)03/16/2031Class A Common Shares107,723(18)107,723D
Share Appreciation Rights C$9.6 (7)03/16/2031Class C Common Shares221,473(19)221,473D
Share Appreciation Rights A$6.78 (7)03/11/2032Class A Common Shares165,393(20)165,393D
Share Appreciation Rights C$6.56 (7)03/11/2032Class C Common Shares340,040(21)340,040D
Share Appreciation Rights A$5.47 (7)03/20/2033Class A Common Shares171,833(22)171,833D
Share Appreciation Rights C$5.3 (7)03/20/2033Class C Common Shares353,279(23)353,279D
Share Appreciation Rights A$4.31 (24)03/12/2034Class A Common Shares213,114(25)213,114D
Share Appreciation Rights C$4.24 (24)03/12/2034Class C Common Shares438,151(26)438,151D
Share Appreciation Rights A$4.68 (27)03/14/2035Class A Common Shares196,969(28)196,969D
Share Appreciation Rights C$4.54 (27)03/14/2035Class C Common Shares404,958(29)404,958D
Share Appreciation Rights A$5.31 (30)03/13/2036Class A Common Shares174,389(31)174,389D
Share Appreciation Rights C$5.29 (30)03/13/2036Class C Common Shares358,535(32)358,535D
Explanation of Responses:
1. On May 21, 2026, the Issuer announced that an authorized committee of the Issuer's board of directors declared a special dividend on each of its outstanding common shares payable on June 16, 2026 to all holders of record as of 5:00 p.m., New York City time, on June 1, 2026 consisting of a special dividend of 0.10 shares of newly issued 9.0% Fixed Rate Cumulative Perpetual Redeemable Series A Preferred Shares (the "Preferred Shares"), having an initial liquidation price of $25 per Preferred Share (the "Dividend"). As a result of the Dividend, the reporting person directly received 88,634 Preferred Shares.
2. Each Restricted Share Unit P ("RSU") represents a right to receive one share of the Issuer's Series A Preference Shares at settlement.
3. In connection with the Dividend, all RSUs with respect to the Issuer's common stock ("Original RSUs") were adjusted pursuant to the anti-dilution provisions of the incentive plans under which the RSU awards held by the reporting person were granted. Each holder of an Original RSU was entitled to receive an RSU with respect to a number of Preferred Shares equal to 0.10 multiplied by the number of shares of common stock underlying the Original RSU, subject to the same terms and conditions as the Original RSU. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
4. The Restricted Share Units vest in full on March 15, 2027.
5. The RSUs vest in two equal annual installments on March 15 of 2027 and 2028.
6. The RSUs vest in three equal annual installments on March 15 of 2027, 2028 and 2029.
7. The derivative security is fully vested.
8. This SAR was previously reported as a SAR relating to 11,854 shares of the Issuer's common stock at a base price of $21.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
9. This SAR was previously reported as a SAR relating to 23,708 shares of the Issuer's common stock at a base price of $21.39 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
10. This share appreciation right award ("SAR") was previously reported as a SAR relating to 28,935 shares of the Issuer's common stock at a base price of $18.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
11. This SAR was previously reported as a SAR relating to 57,870 shares of the Issuer's common stock at a base price of $18.24 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
12. This SAR was previously reported as a SAR relating to 28,345 shares of the Issuer's common stock at a base price of $19.91 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
13. This SAR was previously reported as a SAR relating to 56,690 shares of the Issuer's common stock at a base price of $20.03 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
14. This SAR was previously reported as a SAR relating to 50,939 shares of the Issuer's common stock at a base price of $10.42 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
15. This SAR was previously reported as a SAR relating to 101,878 shares of the Issuer's common stock at a base price of $10.48 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
16. This SAR was previously reported as a SAR relating to 100,000 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
17. This SAR was previously reported as a SAR relating to 200,000 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
18. This SAR was previously reported as a SAR relating to 75,331 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
19. This SAR was previously reported as a SAR relating to 150,662 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
20. This SAR was previously reported as a SAR relating to 115,660 shares of the Issuer's common stock at a base price of $9.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
21. This SAR was previously reported as a SAR relating to 231,320 shares of the Issuer's common stock at a base price of $9.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
22. This SAR was previously reported as a SAR relating to 120,163 shares of the Issuer's common stock at a base price of $7.81 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
23. This SAR was previously reported as a SAR relating to 240,326 shares of the Issuer's common stock at a base price of $7.78 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
24. The SARs vest fully on March 15 2027.
25. This SAR was previously reported as a SAR relating to 149,031 shares of the Issuer's common stock at a base price of $6.16 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
26. This SAR was previously reported as a SAR relating to 298,062 shares of the Issuer's common stock at a base price of $6.22 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
27. The Share Appreciation Rights vest in two equal annual installments commencing on March 15 2027 and 2028.
28. This SAR was previously reported as a SAR relating to 137,741 shares of the Issuer's common stock at a base price of $6.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
29. This SAR was previously reported as a SAR relating to 275,482 shares of the Issuer's common stock at a base price of $6.66 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
30. The Share Appreciation Rights vest in three equal annual installments on March 15 of 2027, 2028 and 2029.
31. This SAR was previously reported as a SAR relating to 121,951 shares of the Issuer's common stock at a base price of $7.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
32. This SAR was previously reported as a SAR relating to 243,902 shares of the Issuer's common stock at a base price of $7.77 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
Remarks:
The trading symbols for the Issuer's classes of common shares are LILA, LILAB, and LILAK, and the trading symbol for the Issuer's Series A Preference Shares is LILAP.
/s/ John M. Winter, Attorney-in-Fact07/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR